Supply of Passage Supply for Patients in Buses Mulchen-Los Angeles of the Mulchen Hospital

ChileTenders notice for Supply of Passage Supply for Patients in Buses Mulchen-Los Angeles of the Mulchen Hospital. The reference ID of the tender is 117685624 and it is closing on 02 May 2025.

100% Secure Payments

Tender Details

  • Country: Chile
  • Summary: Supply of Passage Supply for Patients in Buses Mulchen-Los Angeles of the Mulchen Hospital
  • CLT Ref No: 117685624
  • Deadline: 02 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 1057418-6-LQ25
  • Purchaser's Detail :
  • Purchaser : MULCHEN BIO HOSPITAL BIO BIO HOSPITAL
    Villagra No 455
    Mulchen
    Email :noemi.zagal@ssbiobio.cl

  • Description :
  • These bidding bases will govern the process for hiring agreement for the transfer of bus patients traveled Mulchen-Los Angeles of the Mulchen Hospital, according to the request for acquisition HFCM 31901 issued by Chief Social Service.
    Products or Services: Services: Services: Servicesof hired buss
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
ChileTenders Features

ChileTenders Features

Fresh and verified Tenders from Chile. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Chile in your email inbox.

  Chat with us